Login to Your Account

Other News To Note

Thursday, November 17, 2011
• Aldagen Inc., of Durham, N.C., published a paper in the Journal of Stem Cell Research & Therapy describing the mechanisms by which its cell therapy products promoted formation of new blood vessels in ischemic tissues. The products induced expression of angiogenic genes encoding soluble growth factors, regulatory molecules and extracellular molecules that protect endothelial tubules from hypoxia-induced damage. Aldagen has clinical-stage programs targeting ischemia in the heart, brain and limbs.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription